Study Indicates Decreasing Prescription Copayments Results In Increased Adherence For Patients With Chronic Diseases
Removing economic barriers to treatment for chronic conditions encourages patients to remain on recommended therapies according to a new study published today in the January/February 2008 issue of Health Affairs. The study, funded, in part, by GlaxoSmithKline, investigated the impact on medication adherence of reducing prescription copayments -- in addition to existing disease management programs -- for employees of a leading service industry company.
Although a lack of medication adherence can be attributed to several factors, the effects of high prescription drug copayments have been studied extensively since they have often been used by employers and insurers to control drug expenditures. Increasing copayments has been